Physician leadership and hospital ranking: Expanding the role of neurosurgeons

Abstract

Background:Empirical studies that explore whether hospitals with physician leadership perform better than hospitals led by nonphysician managers are scarce. This study looks at the leaders currently being hired by hospitals in the Arab World and explores whether chief executive officers (CEOs) in hospitals ranked higher are typically physician leaders or nonphysician managers. Furthermore, we discuss whether physicians, especially neurosurgeons, are equipped to lead hospitals and healthcare institutions worldwide.Methods:The “Ranking Web of World Hospitals” by Cybermetrics Lab, 2017, was used. A dataset on CEOs in the top 50 hospitals and the bottom 50 hospitals in the Arab World was constructed. Independent samples t-test and regression equations were conducted, and P values <0.05 were considered statistically significant.Results:A total of 283 hospitals were ranked. Among the top 50 hospitals, 54% of the CEOs were physicians, whereas the remaining were nonphysician managers. Among the bottom 50 hospitals, 74% of the CEOs were physicians, whereas 26% of the CEOs were nonphysicians. Interestingly, physician leadership was significantly associated with lower hospital ranking (bottom 50 hospitals) in the Arab World (P = 0.0031).Conclusion:This article does not establish that nonphysician managers make more effective leaders when compared with physicians, but it starts an empirical course. For better evaluation of hospital leadership qualities, a new hospital ranking system must be created that focuses on patient satisfaction and perception of quality. Physician leaders, especially academic neurosurgeons, are an extraordinary leadership source, combining sound management with high medical standards. With the right academic training, neurosurgeons can play an increasingly significant role in addressing the challenges facing healthcare today.

Health communication research in the Arab world: A bibliometric analysisHealth communication research in the Arab world: A bibliometric analysis

“…The poor status of biomedical research in the Arab world, in general, can be a major reason behind the low output in health communication 41–43. The lack of infrastructure and the continuous migration of researchers towards Western countries that offer better living and work opportunities exacerbate the problem 6 42. More importantly, political instability and military conflicts in many of the Arab states,44 like Syria, Yemen, Iraq, Palestine and Libya, are a major obstacle for the development of clinical research, in general, and health communication, in specific.…”

“…In the past two decades, the health scene in the Arab world has become increasingly intricate. Although countries of the Arab world are pretty diverse, most of the 22 countries that comprise the Arab League and share the common language of Arabic are embroiled in conflict, instability, poverty and/or corruption 6. This takes its toll on the health sector, whereby the need to address public health problems like war injuries, refugee crises, pollution, and communicable and non-communicable diseases rises 7…”

Health communication in low-income countries: A 60-year bibliometric and thematic analysis

“…The lack of academic freedom, poverty, political instability, and conflict are important contributors of low research output. [ 1 61 62 63 64 ] With the rapid rise in use and popularity of social media platforms, health communication, as a field, will become a major tool to address public and global health needs. [ 65 ] As such, more efforts ought to be exerted to promote a research culture that make use of the current rise of communication media to promote healthy lifestyles and habits in LICs.…”

Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations

“…62 This would save time and allow the physician to focus on optimizing patient treatment and bettering clinical outcomes. 63,64 In addition, recent studies have shown that the use of AI can help reduce the amount of contrast agents used in imaging, like gadolinium, while significantly improving the quality of MRI. 65 This would prevent contrast-related toxicity and accumulation in brain tissue.…”